Bridgeway Capital Management, LLC Ampio Pharmaceuticals, Inc. Transaction History

Bridgeway Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.42 - $0.62 $71,816 - $106,015	-170,992 Reduced 21.98%	606,800 $285,000
Q4 2021 Feb 14, 2022	SELL	$0.56 - $1.71 $66,644 - $203,503	-119,008 Reduced 13.27%	777,792 $443,000
Q3 2021 Nov 15, 2021	SELL	$1.21 - $1.8 $151,250 - $225,000	-125,000 Reduced 12.23%	896,800 $1.49 Million
Q2 2021 Aug 16, 2021	SELL	$1.56 - $1.98 $154,284 - $195,822	-98,900 Reduced 8.82%	1,021,800 $1.71 Million
Q4 2020 Feb 16, 2021	SELL	$0.75 - $2.76 $37,500 - $138,000	-50,000 Reduced 4.27%	1,120,700 $1.78 Million
Q2 2020 Aug 14, 2020	BUY	$0.47 - $0.72 $550,229 - $842,904	1,170,700 New	1,170,700 $746,000
Q4 2018 Feb 14, 2019	SELL	$0.39 - $0.7 $39,000 - $70,000	-100,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$1.66 - $3.82 $166,000 - $382,000	100,000 New	100,000 $220,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.